Cancer Vaccines

Milford Medical Laboratory Offers No-False-Positive DNA-sequencing Human Papillomavirus (HPV), Chlamydia and Gonococcus Tests

Published in Vaccine Weekly, August 8th, 2007

The nation's first routine test for sexually transmitted infections (STIs) using DNA sequencing which eliminates the false positive test results associated with other methods, is now available to physicians and their patients, said Suri Pappu, MD, director of Milford Medical Laboratory and chairman of the department of Pathology at Milford Hospital.

A false positive diagnosis of STIs can have adverse medical, social and psychological impacts on a patient, said Sin Hang Lee, MD, who initiated and developed the DNA sequencing test based on a new LoTemp(TM) PCR amplification technology. With DNA sequencing, once a signature sequence is identified, it can only come from one...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Vaccine Weekly

Source: Vaccine Weekly (2007-08-08)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry